BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25998027)

  • 1. Leptin: From structural insights to the design of antagonists.
    Zabeau L; Peelman F; Tavernier J
    Life Sci; 2015 Nov; 140():49-56. PubMed ID: 25998027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20 years of leptin: insights into signaling assemblies of the leptin receptor.
    Peelman F; Zabeau L; Moharana K; Savvides SN; Tavernier J
    J Endocrinol; 2014 Oct; 223(1):T9-23. PubMed ID: 25063754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of non-competitive leptin antagonists using a random nanobody-based approach.
    Zabeau L; Verhee A; Catteeuw D; Faes L; Seeuws S; Decruy T; Elewaut D; Peelman F; Tavernier J
    Biochem J; 2012 Jan; 441(1):425-34. PubMed ID: 21851341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases.
    Peelman F; Waelput W; Iserentant H; Lavens D; Eyckerman S; Zabeau L; Tavernier J
    Prog Lipid Res; 2004 Jul; 43(4):283-301. PubMed ID: 15234549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of leptin and its implications in breast cancer: a general view.
    García-Robles MJ; Segura-Ortega JE; Fafutis-Morris M
    J Interferon Cytokine Res; 2013 Dec; 33(12):717-27. PubMed ID: 23869900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeting of obesity pathways in cancer.
    Surmacz E; Otvos L
    Horm Mol Biol Clin Investig; 2015 May; 22(2):53-62. PubMed ID: 25879324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel leptin receptor antagonist uncouples leptin's metabolic and immune functions.
    Zabeau L; Wauman J; Dam J; Van Lint S; Burg E; De Geest J; Rogge E; Silva A; Jockers R; Tavernier J
    Cell Mol Life Sci; 2019 Mar; 76(6):1201-1214. PubMed ID: 30659329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug targeting of leptin resistance.
    Santoro A; Mattace Raso G; Meli R
    Life Sci; 2015 Nov; 140():64-74. PubMed ID: 26071010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin-Activity Modulators and Their Potential Pharmaceutical Applications.
    Greco M; De Santo M; Comandè A; Belsito EL; Andò S; Liguori A; Leggio A
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of leptin receptor modulators.
    Leggio A; Catalano S; De Marco R; Barone I; Andò S; Liguori A
    Eur J Med Chem; 2014 May; 78():97-105. PubMed ID: 24681069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the therapeutic potential of leptin signaling in cachexia.
    Mak RH; Cheung WW; Gertler A
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):352-7. PubMed ID: 25259544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity.
    Beccari S; Kovalszky I; Wade JD; Otvos L; Surmacz E
    Peptides; 2013 Jun; 44():127-34. PubMed ID: 23567149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring leptin antagonism in ophthalmic cell models.
    Scolaro L; Parrino C; Coroniti R; Otvos L; Surmacz E
    PLoS One; 2013; 8(10):e76437. PubMed ID: 24098500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early leptin blockade predisposes fat-fed rats to overweight and modifies hypothalamic microRNAs.
    Benoit C; Ould-Hamouda H; Crepin D; Gertler A; Amar L; Taouis M
    J Endocrinol; 2013 Jul; 218(1):35-47. PubMed ID: 23576026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and mechanistic paradigm of leptin receptor activation revealed by complexes with wild-type and antagonist leptins.
    Moharana K; Zabeau L; Peelman F; Ringler P; Stahlberg H; Tavernier J; Savvides SN
    Structure; 2014 Jun; 22(6):866-77. PubMed ID: 24882746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin and cardiovascular diseases.
    Hou N; Luo JD
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in leptin signaling from a structural perspective and its implications for diseases.
    Fan X; Yuan W; Huang W; Lin Z
    Biochimie; 2023 Sep; 212():60-75. PubMed ID: 37080418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity.
    Oswal A; Yeo G
    Obesity (Silver Spring); 2010 Feb; 18(2):221-9. PubMed ID: 19644451
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptin signaling in breast cancer: an overview.
    Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
    J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin.
    Drew JE
    Proc Nutr Soc; 2012 Feb; 71(1):175-80. PubMed ID: 22014041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.